Table 5.

Clinical outcomes of all patients in the two groups.

	GROUP I (TIMI 3 FLOW) (N = 415) (86.5%)	GROUP II (NO-REFLOW) (N = 65) (13.5%)	P VALUE
Mortality, n (%)	15 (3.6%)	6 (9.2%)	0.040*
Major bleeding, n (%)	5 (1.2%)	1 (1.5%)	0.822
Cardiogenic shock, n (%)	14 (3.4%)	12 (18.5%)	0.001*
Cardiac arrest, n (%)	9 (2.2%)	5 (7.5%)	0.014*
Heart failure, n (%)	48 (11.6%)	13 (20.0%)	0.058
Contrast-induced nephropathy, n (%)	42 (10.1%)	12 (18.5%)	0.048*
Re-infarction, n (%)	11 (2.7%)	4 (6.2%)	0.131